Collaboration to develop MIV-170.
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans
D000998:Antiviral Agents